Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ryan Hilbelink"'
Autor:
Monika A. Izano, Nguyet Tran, Alan Fu, Liz Toland, Danny Idryo, Ryan Hilbelink, Huakang Tu, Hil Hsu, Chris Sommers, Matthew Rioth, Thomas Brown
Publikováno v:
Clinical Lung Cancer. 23:191-194
To accelerate drug approvals while maintaining scientific rigor in the evaluation of a therapeutic's efficacy and safety, the United States Food and Drug Administration now considers real-world data (RWD) to support New Drug Applications and expanded
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f6dfcad5547a30f17f2ef5b6993d2c
https://doi.org/10.1016/j.cllc.2022.01.002
https://doi.org/10.1016/j.cllc.2022.01.002
Autor:
Chris Sommers, Nguyet Tran, Huakang Tu, Hil Hsu, Alan Fu, Liz Toland, Thomas D. Brown, Ryan Hilbelink, Matthew J. Rioth, Monika A Izano
Publikováno v:
Journal of Clinical Oncology. 39:e21121-e21121
e21121 Background: Treatment response to anti-cancer therapies for advanced lung cancer is usually assessed according to the Response Evaluation Criteria in Solid Tumors (RECIST), which is not generally applied in real-world settings. With real-world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db1ab170eed5ef2c7bebe7036b8bf077
https://doi.org/10.1200/jco.2021.39.15_suppl.e21121
https://doi.org/10.1200/jco.2021.39.15_suppl.e21121